DOSSIER · 13F Holders · Q2 2026

APELLIS PHARMACEUTICALS CVR from 03753U106

4 institutions still hold APELLIS PHARMACEUTICALS CVR from 03753U106 as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 037CVR016·4 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
—
visible holders
Holders
4
filers reporting
Concentration
—
Financial Gravity Companies, Inc. #1
top holder share
AI Holders Summary · Q2 2026

4 institutions reported APELLIS PHARMACEUTICALS CVR from 03753U106 in Q2 2026. Top-holder concentration data is loading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Financial Gravity Companies, Inc.
CIK 0001377167
$01000.00%Q2 2026
02
Salomon & Ludwin, LLC
CIK 0001766156
$08500.00%Q2 2026
03
Archer Investment Corp
CIK 0001803804
$01K0.00%Q2 2026
04
NBT BANK N A /NY
CIK 0000898413
$0450.00%Q2 2026